Von Hippel-Lindau disease (VHLD)

Authors

  • Jorge Luis González Jara Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Keywords:

Hippel-Lindau disease/history, follow-up studies

Abstract

Von Hippel-Lindau disease is one the 7000 known hereditary disorder. It is named after Dr. Eugen von Hippel; a German ophthalmologist who was the first to described the ocular angiomas in 1895. Equally, Dr. Arvid Lindau, a Swedish pathologist, begins the study of the angiomas in the cerebellum and the spinal cord marrow in 1926. His description includes a systematic recompilation of all the cases published up to that time, including those described by von Hippel, but adding also the alterations in other abdominal organs. It is an autosomal dominant neoplasia syndrome caused by the deletion or mutation of the tumor suppressor gene of the 3p25 chromosome, characterized by the presence of benign and malignant tumors affecting several organs and systems such as: the central nervous system, the pancreas, the adrenal glands and the paranodes. In general, the disease is hereditary; but the health problems affecting the patients can be so varied that the common cause may not be identified. Besides, the appearance and severity of the disease have a great variation, and within the same family there are individuals slightly affected while others present more serious manifestations.

Downloads

Download data is not yet available.

Author Biography

Jorge Luis González Jara, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Cirugía General. Profesor Instructor de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

Downloads

How to Cite

1.
González Jara JL. Von Hippel-Lindau disease (VHLD). Acta Méd Centro [Internet]. 2009 Sep. 12 [cited 2025 Jul. 16];3(3):60-6. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/465

Issue

Vol. 3 No. 3 (2009): September-December

Section

Review Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).